Souhaitez-vous accéder aux communiqués récents ?

SoCalBio's 27th Investor & Partnership Conference (Oct. 1-2) to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation.

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Keynotes for the 27th SoCalBio Conference will be delivered by Murthy Simhambhatla, PhD (SetPoint Medical) and Raymond W. Cohen (formerly Axonics).

OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device has received approval from the...

Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of life Most...

SoCalBio has unveiled the updated lineup of 22 emerging bioscience companies and confirmed investors for its 27th annual Investor Conference, Oct. 1-2.

          Focal One® HIFU Receives Prestigious Innovation Award AUSTIN, Texas, September 16, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today...

RUTHERFORD, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System.